The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital (MGH), has been awarded a $398,587 Project Grant from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) federal grant program. This 5-year grant, with an award date of August 1, 2024 and ultimate completion date of May 31, 2029, will support MGH's research examining the relative value of Medicare Advantage (MA) plans versus Traditional Medicare (TM) for dual-eligible Medicare and Medicaid beneficiaries. The study will analyze longitudinal enrollment patterns, assess the impact of MA versus TM on Medicaid utilization and spending including long-term services and supports and behavioral health services, and evaluate Medicare utilization and outcomes such as prescription drug adherence, hospitalizations, post-acute care, and mortality. The research aims to provide evidence on the effects of MA enrollment for this vulnerable population and address potential selection bias through leveraging a natural experiment created by recent policies.
Generated 2/25/25, 1:53 AM